EMAIL THIS PAGE TO A FRIEND

Molecular pain

CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy.


PMID 24961298

Abstract

Painful Diabetic Neuropathy (PDN) is a debilitating syndrome present in a quarter of diabetic patients that has a substantial impact on their quality of life. Despite this significant prevalence and impact, current therapies for PDN are only partially effective. Moreover, the cellular mechanisms underlying PDN are not well understood. Neuropathic pain is caused by a variety of phenomena including sustained excitability in sensory neurons that reduces the pain threshold so that pain is produced in the absence of appropriate stimuli. Chemokine signaling has been implicated in the pathogenesis of neuropathic pain in a variety of animal models. We therefore tested the hypothesis that chemokine signaling mediates DRG neuronal hyperexcitability in association with PDN. We demonstrated that intraperitoneal administration of the specific CXCR4 antagonist AMD3100 reversed PDN in two animal models of type II diabetes. Furthermore DRG sensory neurons acutely isolated from diabetic mice displayed enhanced SDF-1 induced calcium responses. Moreover, we demonstrated that CXCR4 receptors are expressed by a subset of DRG sensory neurons. Finally, we observed numerous CXCR4 expressing inflammatory cells infiltrating into the DRG of diabetic mice. These data suggest that CXCR4/SDF-1 signaling mediates enhanced calcium influx and excitability in DRG neurons responsible for PDN. Simultaneously, CXCR4/SDF-1 signaling may coordinate inflammation in diabetic DRG that could contribute to the development of pain in diabetes. Therefore, targeting CXCR4 chemokine receptors may represent a novel intervention for treating PDN.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1401144
Anti-FPR2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA029154 Anti-FPR2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV43141
Anti-MKRN1 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV43142
Anti-MKRN1 (AB2) antibody produced in rabbit, IgG fraction of antiserum
SAB2501704
Anti-MKRN1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501717
Anti-MKRN1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2102989
Anti-TRIM27 antibody produced in rabbit, affinity isolated antibody
SAB2700796
Anti-TRIM27 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2700798
Anti-TRIM27 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2700971
Anti-TRIM27 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA048684
Anti-TRIM27 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1403837
Monoclonal Anti-FPRL1 antibody produced in mouse, clone 2G8, purified immunoglobulin, buffered aqueous solution
SAB1402202
Monoclonal Anti-FPRL1 antibody produced in mouse, clone 2D8, purified immunoglobulin, buffered aqueous solution
WH0023608M1
Monoclonal Anti-MKRN1 antibody produced in mouse, clone 4E9, purified immunoglobulin, buffered aqueous solution